The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcome
10.1038/sj.bjc.6604899
Saved in:
Main Authors: | Soong, R., Nilesh Manubhai Shah, Peh, B.K., Chong, P.Y., Ng, S.S., Salto-Tellez, M., Ito, Y., Zeps, N., Joseph, D., Barry John Iacopetta |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/27082 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
RUNX3 is multifunctional in carcinogenesis of multiple solid tumors
by: Chuang, L.S.H., et al.
Published: (2011) -
CD133 expression predicts for non-response to chemotherapy in colorectal cancer
by: Ong, C.W., et al.
Published: (2012) -
Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells
by: Ju, X., et al.
Published: (2016) -
Neuroblastoma cell proliferation is sensitive to changes in levels of RUNX1 and RUNX3 protein
by: Inoue, K.-I., et al.
Published: (2016) -
Down-regulation of RUNX1, RUNX3 and CBFβ in hepatocellular carcinomas in an early stage of hepatocarcinogenesis
by: Miyagawa, K., et al.
Published: (2011)